Taipei | October 17, 2024 YC Biotech CO., LTD. announced recently that it has signed a Memorandum of Understanding (MOU) with YD Biopharma Co., Ltd. to jointly advance the development and clinical trials of LENSMATE contact lenses and EXOLENS corneal tear-related products, derived from human limbal stem cell (LSC) technology. Under the terms of the […]
Taipei City | Date: September, 2024 YC Biotech CO., LTD. is excited to announce its official collaboration with Sentronic International Corp. to launch the clinical trial for the G-BeBite® Dental Implant System. This groundbreaking project, commissioned by Sentronic International Corp., designates YC Biotech as the contracted research organization (CRO), responsible for designing, planning, and executing the
Location: Manama, Bahrain | Date: June 18, 2024 YC Biotech CO., LTD. was honored to participate in a prestigious medical conference organized by the Economic Development Board (EDB Bahrain). Representing Taiwan’s biotechnology industry, YC Biotech showcased its groundbreaking advancements in stem cell exosome technology and cancer methylation detection to key officials and medical experts in
Taipei City | Date: December 6, 2023 YC Biotech has officially launched a groundbreaking spine regeneration research project, utilizing an innovative stem cell and hydrogel composite system to explore novel treatment approaches for degenerative spinal conditions. This eighteen-month research project will commence in December 2023 and is expected to continue until June 2025. The study
YC Biotech and Friendly Taipei Community Health Care Group successfully held a signing event at Brown Cafe, announcing their partnership to promote EG BioMed’s DNA Methylation Cancer Biomarker Test. This collaboration marks a significant advancement in breast cancer detection methods, with the technology standing out for its simplicity, speed, and accuracy, offering a more comfortable
Taipei City | Date: November 7, 2023 YC Biotech Co., Ltd. recently conducted animal trials for the G-BeBite dental implant system, with promising results from performance studies on the mandibular bone of Lanyu miniature pigs. Early data indicates that this implant system demonstrates exceptional osseointegration and favorable safety in local biocompatibility tests, further reinforcing its
YC Biotech Corporation and Xindian-Wenshan Community Health Care Group have officially joined forces to introduce EG BioMed’s DNA methylation cancer indicator testing technology to the Taiwan market. The partnership was celebrated on the 17th with a signing ceremony banquet at Su-Hang Restaurant, where both parties reaffirmed their commitment to making innovative cancer detection more widely
YC Biotech and New Keelung Community Health Care Group announce successful signing event at Bambino Italian Restaurant to promote the application of EG BioMed’s DNA methylation cancer biomarker test in breast cancer. This innovative testing technology has garnered attention in the industry for its “simple, fast, and accurate” features. The breast cancer detection sensitivity and
